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Abbreviations  
BP blood pressure 
CAD coronary artery disease 
CVD cardiovascular disease 
DBP diastolic blood pressure 
eNOS endothelial nitric oxide synthase  
FMD flow mediated dilution 
MS metabolic syndrome 
NO nitric oxide 
NOS nitric oxide synthase 
PWV pulse wave velocity 
SBP systolic blood pressure 
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Abstract 
Flavonoids, naturally occurring secondary metabolites in plants, have been 
associated with positive effects on high blood pressure (hypertension) which 
is one of the most important risk factors for cardiovascular disease. 
Anthocyanins, a subgroup of flavonoids, have in more recent years gained 
particular attention for its effects on blood pressure.  
 The aim of this literature review was to investigate the scientific 
evidence for potential beneficial effects of anthocyanins on hypertension 
and identify possible mechanisms for such effects. 
Long term epidemiological studies indicate that anthocyanins do have 
positive effects on blood pressure as well as maintaining normal vascular 
function. Several randomized controlled trials (RCTs) have also observed 
beneficial effects of anthocyanins but there are also several studies which 
have not observed any effects at all. Mechanistic animal studies indicate that 
vaso-relaxing properties from the anthocyanins may be responsible for the 
effects on blood pressure through the upregulation of nitric oxide synthesis, 
(NOS).  
In conclusion, some studies indicate positive effects on blood pressure 
owed to anthocyanins, but more studies are needed to prove cause-effect. 
The observed vaso-relaxing effects are most likely due to the activity of NO 
which seem to be influenced by the metabolites derived from anthocyanins. 
  
Keywords: anthocyanidins, anthocyanins, cardiovascular health, 
hypertension, blood pressure, NO 
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Sammanfattning 
Flavonoider, naturligt förekommande sekundära metaboliter hos växter, har 
visat sig ha positiva effekter på högt blodtryck (hypertoni), en av de 
viktigaste riskfaktorerna för kardiovaskulära sjukdomar. Effekterna har 
särskilt kopplats till en undergrupp av flavonoiderna; antocyaniner. 
Syftet med denna litteraturstudie var att undersöka om antocyaniner har 
positiva effekter på hypertoni och vilka mekanismer som kan ligga bakom 
effekterna. 
Epidemiologiska långtidsstudier har ofta påvisat positiva effekter av 
antocyaniner på blodtryck och kärlfunktion, men kausalitet kan ej 
säkerställas genom denna typ av studier. Flera randomiserade, kontrollerade 
studier har påvisat positiva effekter medan andra studier inte uppvisat några 
effekter alls. Mekanistiska djurstudier ger stöd för att effekterna beror på en 
ökad produktion av kväveoxid syntas. 
Sammanfattningsvis visar sammanställningen att det finns studier som 
observerat blodtryckssänkande effekter av antocyaniner, men att fler studier 
behövs för att säkerställa kausalitet. Mycket tyder på att observerade 
vasorelaxerande effekter beror på aktivitet från NO som kan påverkas 
positivt av antocyaninmetabolitet. 
 
Nyckelord: antocyanidiner, antocyaniner, kardiovaskulär sjukdom, 
hypertoni, blodtryck, NO 
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1. Introduction 
A high intake of fruits and vegetables has been strongly associated with 
beneficial effects on several diseases such diabetes and cardiovascular 
diseases (CVDs) (Wang et al., 2016; Turati et al., 2015). Besides the high 
nutritional value in fruits and vegetables, several studies have concluded 
that flavonoids, secondary metabolites of plants, have positive effects on the 
regulation of blood pressure (Lajous et al., 2016; Barona et al., 2012; 
Jennings et al., 2012; Cassidy et al., 2011; Zhu et al., 2011; Erlund et al., 
2008). Elevated blood pressure (hypertension) is one of the most common 
risk factors for developing cardiovascular diseases, the leading cause of 
death worldwide. Preventing development of hypertension involves physical 
activity and a balanced diet (WHO, 2014).  
In recent years, anthocyanins have gained more attention and have been 
associated with lowering of blood pressure (Lajous et al., 2016). 
Anthocyanins are flavonoids which are responsible for the blue, red and 
violet colors of plants. The widely distribution of anthocyanins in berries 
have led to the use of berries as the antocyanin source in many randomized 
controlled trials (RCTs). Most of the observed beneficial effects of 
anthocyanins have been derived from long term epidemiological studies 
which are observational studies (Lajous et al., 2016; Jennings et al., 2012; 
Cassidy et al., 2011). Results from RCTs are mixed (Zhu et al., 2011; Basu 
et al., 2010a; Basu et al., 2010b; Stull et al., 2010).  
This literature review aimed to investigate if there is a scientific support 
for a positive effect of anthocyanins on blood pressure and hypertension. 
The aim was further to identify potential mechanisms for such an effect. 
Both epidemiological and RCT studies were included in the survey as well 
as some animal studies for further understanding of the mechanisms behind 
the effects. A short summary of the findings on the bioavailability of 
anthocyanins and possible mechanisms of action is also included.  
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2. Hypertension 
Cardiovascular disease, CVD, is rated as the number one cause for deaths 
worldwide and includes a number of dysfunctionalities of the heart and 
blood vessels. Presence of behavioral risk factors, such as use of tobacco, 
unhealthy diets and inactivity, may in turn lead to medical risk factors. 
Raised blood glucose, raised blood pressure (hypertension) and raised blood 
lipids are all associated with the risk of strokes and heart attacks (WHO, 
2016).  
Hypertension (Systolic blood pressure (SBP)/Diastolic blood pressure 
(DBP) ≥140/90 mmHg) has been identified in 22% of the adult population 
(age >18) globally, and is therefore one of the leading risk factors for CVD. 
In 2010, hypertension was estimated to be responsible for the death of 9.4 
million people (WHO, 2014). Raised blood pressure puts the blood vessels 
under stress and may lead to weakening and rupture of the vessels. 
Hypertension may also lead to narrowing of the vessels and the risk of 
blocking the passage by blood clots or fats increases (WHO, 2015). 
Hypertension has been associated with endothelial dysfunction (Vita, 
2005) and the clinical symptoms of CVD risk factors are related to loss of 
endothelial control of vascular homeostasis (Widlansky et al., 2003). 
Endothelial antiatherosclerotic and antithrombotic properties are reduced 
during endothelium dysfunction which demonstrates the importance of the 
endothelium (Perticone et al., 2001). If hypertension causes endothelial 
dysfunction or vice versa is yet to be established but the available data seem 
to suggest that they reinforce each other (Dharmashankar & Widlansky, 
2010).  
The epithelium maintains normal vascular tone by producing 
vasodilators and vasoconstrictors that act locally. One of the vasodilators is 
nitric oxide (NO) which also inhibits the adherence of leukocytes to the 
endothelial walls thus prevents platelet adhesion and aggregation (Ignarro et 
al., 1987). Studies have observed a heavy reduction of the effects of the 
regulation mechanism when the effects of NO were inhibited (Madrid et al., 
1997; Cowley et al., 1992). Blockage of NO synthase in rats lead to the 
development of hypertension, indicating that blood pressure is regulated by 
the endothelial-derived production of NO (Dananberg et al., 1993).The 
epithelium also controls the fluidity of the blood as well as the coagulation 
process by producing factors that ex. regulates platelet activity. CVD risk 
factors induces a chronic inflammatory process which decreases 
vasodilators and anti-thrombotic factors while vasoconstrictors and pro-
thrombotic products are increased (Widlansky et al., 2003). Vascular 
disorders such as hypertension impairs the vasomotor functions of the 
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endothelium thus the vascular regulation via NO loses its efficiency (Lazzè 
et al., 2006). The mechanism involves the decrease of NO production and 
responsiveness of the vascular smoot muscle cells to NO (Lüscher, 1992) 
which implements endothelial dysfunction (Perticone et al., 2001). 
 Hypertension seems partly to be induced and aggravated by excessive 
reactive oxygen species which can be generated by NADPH oxidase, 
mitochondria, endothelial derived NO synthase and some other cellular 
sources (Kizhakekuttu & Widlansky, 2010). Reactive oxygen species can in 
turn decrease the production of NO by damaging the endothelium or 
chemically decrease the activity of NO (Wallace, 2011) . 
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3. Flavonoids 
Flavonoids are polyphenolic compounds with putative health properties. 
They may be divided into subclasses based on their structure, oxidation state 
and subgroups of the oxygenated ring; flavonols, flavones, flavanones, 
flavan-3-ols and anthocyanins (Figure 1). More than 5000 flavonoids have 
been identified in plants; vegetables, fruits and grains. Flavonoids bound to 
sugar molecules are called flavonoid glycosides and the ones not bound to 
sugar are referred to as aglycones. Contents of flavonoids in plants depend 
on the variety, climate, agricultural practice, maturity at harvest and post-
harvest conditions (Coultate, 2009)(Erdman et al., 2007). 
Several flavonoids have been associated with a reduced risk of CVDs in  
numerous studies (Hollman et al., 2010; Vita, 2005; Geleijnse et al., 2002; 
Rein et al., 2000; Knekt et al., 1996) and lowering of blood pressure and 
vasorelaxing effects (Barona et al., 2012). 
 3.1 Anthocyanins  
Anthocyanins are water soluble polyphenolic pigments responsible for the 
pink, red, violet and blue colors in flowers, fruits and vegetables. They are 
flavonoids widely distributed in nature, found in the vacuoles of plant cells. 
Anthocyanins are the glycosidic form of anthocyanidins of which only six 
different ones are found in nature; pelargonidin, cyanidin, peonidin, 
delphinidin, petunidin and malvinidin (Figure 2). The six anthocyanidin 
aglycones give rise to numerous anthocyanins by different glycosylation 
and acylation patterns. When glycosylated, the sugar residue is always 
found at position 3, often together with a glucose at position 5 or sometimes 
at position 7, 3’ or 4’ (Figure 1). The most common sugar residues are 
glucose, galactose, rhamnose and arabinose (Coultate, 2009).  
O
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Figure 1. The basic structure of flavonoids and anthocyanins (Redrawn from Coultate, 2009) 
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The maximum absorbance of anthocyanidins is just above 500 nm which 
gives rise to a red color in the visible spectrum. The addition of the different 
side groups of the anthocyanidins shown in Figure 2 moves the visible color 
towards purple and blue. The full spectrum of the colors associated to 
anthocyanidins demands changes is pH and presence of other compounds 
which either enhances or weakens the intensity in color. At low pH, 
anthocyanidins are primarily found in the form of a flavylium ion (Figure 2) 
which has a red color. With increasing pH, the flavylium ion loses a proton 
and a colorless molecule, carbinol pseudo-base, is formed instead. With 
higher pH the flavylium ion transforms into a non-ionized quinoidal base 
which gives rise to a purple color. After addition loss of another proton an 
ionized quinoidal base, which have a deep blue color, is formed (Coultate, 
2009). 
 
O+HO
OH
OH
R2
OH
R1
 
Figure 2. The basic structure of the flavylium ion and the sidegroups of the six antocyanidins 
found in nature (redrawn from Coultate, 2009). 
Anthocyanins are synthesized by the plant as a part of the plants chemical 
defense. They are involved in the protection of the plant from invasive 
insects and herbivores but also attracts pollinators. They have also been 
shown to be involved in the UV-protection of the plant. Flavonoids over all 
have demonstrated antioxidant properties by being able to scavenge 
different oxidizing species such as superoxide anions and hydroxyl- and 
peroxy radicals (Harborne & Williams, 2000; Chalker-Scott, 1999). 
Anthocyanins, with cyanidin being the most common aglycone 
(Coultate, 2009), are mainly found in fresh fruits, berries and vegetables, 
such as black currents, grapes, bilberries (Swedish National food agency, 
2016) but also in some cereals, red wine and some leaf and root vegetables 
(Erdman et al., 2007). It has been estimated that Americans consume about 
12.5 mg anthocyanins per day (Wu et al., 2006) but estimations of intake 
vary widely between studies as can be seen in Table 1, where mean intake 
varies from 0.2-71±43 mg/day. The content of anthocyanins varies greatly 
between different food items which is reflected in the large variations in 
Anthocyanidin R1 R2 
Pelargonidin H H 
Cyanidin OH H 
Peonidin OCH3 H 
Delphinidin OH OH 
Petunidin OCH3 OH 
Malvinidin OCH3 OCH3 
9 
intakes. In gooseberries the concentration of anthocyanins have been 
estimated to 0.7 mg/100 g fresh weight compared with chokeberries which 
have been estimated to contain a concentration of 1480 mg 
anthocyanins/100 g fresh weight (Wu et al., 2006).  
 3.2 Bioavailability  
The absorption pathway of anthocyanins seems to deviate compared to the 
pathway of other flavonoids (Fang, 2014; Manach et al., 2005). In rats 
anthocyanins have been shown to be efficiently and rapid absorbed intact in 
the stomach as glycosides and found short thereafter in bile as intact 
molecules and metabolites (Talavéra et al., 2003). However, anthocyanins 
have been reported to be one of the least absorbed polyphenols (Manach et 
al., 2005). Only 0.19±0.02 % of orally ingested blackberry anthocyanins 
(91.2 % cyanidin-3-glucoside) was identified in rat urine 24 hours post 
consumption. Intact blackberry anthocyanins, methylated- and glucurono-
conjugated derivatives were all detected in the urine. In the plasma, 
blackberry anthocyanins, methylated forms of cyanidin, monoglucuronide 
derivatives as well as aglycones were detected. Mainly blackberry 
anthocyanins were detected in the stomach and no metabolites were found, 
indicating that the anthocyanins are absorbed intact. The jejunum was found 
to be the most anthocyanin rich area with blackberry anthocyanins and 
traces of methylated- and aglycone forms and glucurono-conjugated 
derivatives (Talavéra et al., 2005). 
A review by Manach et al. (2005) concluded that anthocyanin 
metabolites appears 1.5 (0.75-4) hours after consumption in the human 
plasma and 2.5 hours in urine. After supplementations ranging from 150 
mg-2 g, the measured concentrations in plasma appeared to be very low (10-
50 nmol/L) and even lower in urine (0.004-0.1%). The observed poor 
absorption of anthocyanins may be due to the rapid metabolism and the fact 
that all of its metabolites have not yet been analyzed and therefore the 
results may be underreported (Manach et al., 2005). A more recent study 
observed a much higher recovery of the anthocyanins in urine and plasma, 
more in line with the recovery percentages of other flavonoids (Czank et al., 
2013). The observed poor absorption may also be due to the sensitivity 
anthocyanins exhibits towards pH-changes. After consumption of 200 g 
strawberries, mostly containing pelargonidin-3-glucoside, a recovery of 1.8 
±0.29%, mainly of glucuro- and sulfoconjugates, was recovered in human 
urine samples. More than 2/3 was excreted after 4 hours. Acidification of 
the urine samples lead to the disappearance of two out of six peaks 
identified by HPLC. In addition, one peak decreased and another peak 
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increased indicating the  instability of some of the metabolites (Felgines et 
al., 2003). 
The low absorption and excretion of anthocyanins was also observed in 
elderly women consuming elderberry extract and blueberries. Excretions of 
0.077 % within four hours respective 0.004 % within six hours were 
observed. The anthocyanins were excreted in their original form, methylated 
and glucuronide conjugates (Wu et al., 2002).  
Additional hydroxyl- and methoxy groups of anthocyanidins, as well as 
anthocyanin glucosides adds to the stability of the molecule (Fleschhut et 
al., 2006). This may be one of the explanations for the many different 
results yielded in studies which have examined metabolites derived from 
food matrixes compared with pure anthocyanins. The parent anthocyanin is 
subsequently often recovered in very small concentrations (Ludwig et al., 
2015; de Ferrars et al., 2014). 
Phenolic acids seem to be the major stable metabolites derived from 
anthocyanins (Fleschhut et al., 2006; Keppler & Humpf, 2005). Phenolic 
acids, mainly hippuric acid, was indeed found in human urine 120 min after 
blackcurrant consumption. Phenolic acids were also detected in plasma, 
peaking at 30 and 180 minutes after consumption (Jin et al., 2011). The fast 
recovery in plasma also indicates the possibility for pH-initiated degradation 
of the anthocyanins in the early gastrointestinal tract (Ludwig et al., 2015).  
Some studies also indicate the impact colon microbiota may have on the 
degradation of anthocyanins into different metabolites. Microbial 
degradation of 13C-labeled cyanidin-3-glucoside into hydroxybensoic acid in 
humans was observed in one study (de Ferrars et al., 2014) and the recovery 
of phenylacetic acid in human plasma 6 hours post supplementation of 
raspberry anthocyanins, indicated both microbial degradation and 
absorption in the colon (Ludwig et al., 2015).  
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4. The effects of anthocyanins on blood pressure 
4.1 Epidemiological studies 
Several observational studies have investigated the association between 
different flavonoid subclasses, including anthocyanins, and CVD risk 
factors, such as hypertension and elevated blood pressure. Such studies are 
summarized for comparison in Table 1 and information regarding 
participants, sources and doses of anthocyanins used and observed results 
on hypertension related factors are shown. 
In large population based studies following women of 25-55 years 
(Nurses’ Health Study І and ІІ) and men of 40-75 years (Health 
Professionals Follow-Up Study) during 14 years, anthocyanins were found 
to be strongly associated with a reduced risk of hypertension. Pooled results 
from all three cohorts suggested an 8 % reduced risk for developing 
hypertension among participants with the highest intake of anthocyanin rich 
food compared to the group with the lowest intake. Intake of other 
subclasses of flavonoids was not associated with hypertension. The fact that 
some anthocyanins can act as inhibitors of the endothelial NADPH oxidase, 
an enzyme that limits the bioactivity of NO in the blood vessels was 
suggested as a mechanism behind the observation (Cassidy et al., 2011).  
Another large cohort study investigated the association between 
flavonoid intake and CVD mortality in men and women of 70 respective 69 
years of age during in average 7 years of follow up. The conclusion from 
this study was that some flavonoid classes, including anthocyanins, were 
associated with a lower risk of CVD. The study also observed that 
participants with higher flavonoid intake were, amongst other factors, also 
less likely to have a history of hypertension (McCullough et al., 2012).  
A recent study conducted by Lajous et al. (2016) on healthy French 
women aged 45-58 years observed an inverse association between 
anthocyanin intake and hypertension. About 9 % lower incident of 
hypertension was found in the lowest antocyanin intake quantile compared 
to the highest quintile, after adjustment for other lifestyle factors. However, 
in contrast with Cassidy et al. (2011), this study also found inverse 
association between total flavonoid intake and hypertension incidence 
(Lajous et al., 2016).  
Significant inverse association between anthocyanin intake and CVD 
mortality was also observed in a prospective study on postmenopausal 
women of age 55-69 years. The inverse association was however not 
specific for hypertension since CVD mortality was the investigated endpoint 
of the study (Mink et al., 2007). 
12 
Jennings et al. (2012) conducted a study in women aged 18-75 years and 
observed that anthocyanins were associated with a major impact on blood 
pressure. The total amount of consumed flavonoids did not influence arterial 
stiffness, central blood pressure or atherosclerosis. However, the total 
amount of anthocyanins was associated with a lowered peripheral and 
central systolic blood pressure and mean arterial pressure significantly. The 
study concluded that anthocyanins most probably have a protective role in 
regulation of blood pressure and arterial stiffness (Jennings et al., 2012).  
In conclusion, when it comes to epidemiological studies, intake of 
anthocyanins seems to be associated with beneficial effects on 
cardiovascular disease, hypertension included. Most studies have been 
conducted on female participants of higher age and anthocyanin intake 
varied widely.  
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Table 1. Summary of epidemiological cohort studies investigating association between anthocyanin intake from 
different foods and risk of hypertension or mortality due to cardiovascular diseases.  
♀=women; ♂=men 
4.2 Randomized controlled trials 
Some RCTs have found positive effects of anthocyanins on blood pressure 
(Table 2) and some have not (Table 3). The anthocyanins were often 
administered as different berry extracts, such as freeze-dried powder, juices 
and purees. The participants included most often had some kind of condition 
related to cardiovascular diseases such as metabolic syndrome or diabetes.  
Dohadwala et al. (2011) investigated the effects of cranberry juice on 
vascular function in patients with stable coronary artery disease (CAD) with 
a mean age of 62 ± 8 years both in an acute pilot study and in a crossover 
study. In the acute pilot study brachial artery flow-mediated dilution (FMD - 
a method of measuring endothelial function) was significantly improved 
after 4 hours respective 2 and 4 hours. However, no cumulative effects of 
juice consumption were observed in the crossover study for brachial artery 
flow-mediated dilution, blood pressure or endothelial function. Decrease in 
arterial stiffness was observed as reduced carotid-femoral PWV (Dohadwala 
et al., 2011). 
Intake of anthocyanin-rich blueberries was shown to decrease blood 
pressure in obese participants aged 50.0 ± 3.0 years. The blood pressure had 
improved significantly compared to the control group (Basu et al., 2010a). 
Another study found similar results when lower blood pressure after 
consumption of anthocyanin-rich berries was observed in unmedicated, 
Subjects (n) and 
conditions 
Average 
follow-up 
time 
Anthocyanin 
food source 
Anthocyanin dose 
(mg/d)  
 
Association Reference 
Healthy  
n (♀)=87242+46672 
n (♂)=23043 
14 years Berries 12.5-15.2 Inverse (Cassidy et 
al., 2011) 
Healthy  
n (♀)=60289 
n (♂)=38180 
7 years Berries, wine 3.8 (<5.5)-13.7 (11.5-
16.6)  
Inverse only 
for mortality 
caused by 
cardiovascular 
diseases  
(McCullough 
et al., 2012) 
Healthy  
n (♀)=40574 
14 years Fruits, wine 71 ±43 (39 ± 19.9 – 
94 ±52.6) 
Inverse (Lajous et al., 
2016) 
Postmenopausal  
n (♀)=34489 
16 years Berries, fruits, 
wine, bran, 
chocolate 
0.2 (0.01-1040) Inverse only 
for mortality 
caused by 
cardiovascular 
diseases 
(Mink et al., 
2007) 
 
(♀) 11 years Fruits, wine, 
berries 
17.7±14.9 (8.4-23.6) Inverse (Jennings et 
al., 2012) 
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middle-aged participants with elevated risk of CVD. The effects was 
however only observed in the participants which already possessed elevated 
baseline BP ranging from 133.3-184.7 mmHg (Erlund et al., 2008). 
A more recent study by Rodriguez-Mateos et al., (2013) also 
investigated the impact of blueberry polyphenols on the endothelial function 
in healthy men of 18-40 years. The metabolites from the polyphenols 
improved the vascular function greatly, most probably due to that they were 
able to decrease NADPH oxidase activity. The increase of FMD reached the 
maximum value after 1-2 hours after consumption of 766 mg polyphenols 
of which 310 mg was anthocyanins. The increase of FMD after 6 hours was 
associated with an increase of metabolites derived from anthocyanins and 
chlorogenic acids (Rodriguez-Mateos et al., 2013).  
Zhu et al. (2011) investigated the effects of purified anthocyanins 
derived from blueberries and blackcurrant on endothelial function in a long-
term and a short-term study in hypercholesterolemic patients aged 40-55 
years. After 12 weeks of supplementation, SBP had decreased significantly 
and FMD was increased compared to baseline and placebo. The short-term 
intervention observed increased concentrations of plasma deliphinidin-3-O-
β-glucosides and cyanidin-3-O-β-glucosides (metabolites of anthocyanins) 1 
hour after supplementation. All in all, the anthocyanins improved 
endothelial-dependent vasodilation (FMD) significantly and the mechanism 
was thought to include the activation of the NO-cAMP signaling pathway 
(Zhu et al., 2011).  
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Table 2. Summary of results from randomized controlled trials where statistically significant improvements (+) of 
blood pressure (BP), arterial stiffness measured as pulse wave velocity (PWV) or endothelial function measured by 
flow mediated dilution (FMD) have been observed. 
♂=men; sex not mentioned= both women and men or not mentioned in study 
Subjects (n) 
and 
conditions 
Duratio
n of 
interven
tion 
Anthocyanins 
source 
Dose 
(mg/d) 
Berries 
(g) 
BP Arterial 
stiffness/Endoth
elial function 
Reference 
Coronary 
artery disease 
n=44 
4 weeks  Cranberry  
(juice)  
94    + (PWV) (Dohadwal
a et al., 
2011) 
Metabolic 
syndrome 
n=48 
8 weeks Blueberry (freeze 
dried)  
742  350 +  (Basu et al., 
2010a) 
Increased risk 
of 
cardiovascular 
disease 
n=72 
8 weeks Bilberry 
Lingonberry 
(nectar) 
Blackcurrant/ 
strawberry (purée)  
Chokeberry/ 
Raspberry (juice)   
515  100 + 1 
drink 
+   (Erlund et 
al., 2008) 
n (♂) =21 6 hours Blueberry 310 240  + (FMD) (Rodriguez-
Mateos et 
al., 2013) 
Hypercholeste
rolemic 
n=150 
12 
weeks 
Pure  320   + + (FMD) (Zhu et al., 
2011) 
 
n=12 4 hours   
There are also several RCT studies that have not observed any change in 
blood pressure or any difference compared with control after an intervention 
with polyphenol rich diet (Del Bo′ et al., 2013; Riso et al., 2012; Stull et al., 
2010; McAnulty et al., 2005). A summary of some of these studies are 
presented in Table 3.  
When healthy young men aged 20.8 ± 1.6 years consumed blueberries in 
an acute study conducted by Del Bo´ et al. (2013), no effects on peripheral 
arterial function or BP was observed. The failure to demonstrate an effect 
on peripheral arterial function was thought to be due to the fact that the 
subjects were all healthy. The effects may be easier demonstrated in 
subjects with reduced vascular function. The measurement may also have 
been carried out to soon after intake (1 hour) (Del Bo′ et al., 2013) since 
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maximum concentration of effective metabolites in plasma may appear later 
(Manach et al., 2005). 
Failure to demonstrate significant decrease in BP and peripheral arterial 
function have also occurred in studies where older men aged 47.8 ± 9.7 
years with one risk factor for CVD consumed freeze-dried blueberry 
powder. The 6 weeks intervention study included a large number of 
individuals with differences in CVD-risk factors and a large inter-individual 
variation was seen in the subjects as half of the group did in fact have 
improved values (Riso et al., 2012). 
In obese, insulin resistant men and women with normal blood pressure 
no alteration in BP was found after consumption of anthocyanin rich 
blueberry powder for 6 weeks. It is however unclear how the BP was 
measured since the endpoint of the study was to measure insulin sensitivity 
(Stull et al., 2010). After 3 weeks of consumption of 250 g blueberries/d, 
alterations in BP was not observed in chronic smokers either (McAnulty et 
al., 2005).  
Adults with three of five symptoms of metabolic syndrome consumed 
cranberry juice for 8 weeks. No significant change of BP was observed in 
the study (Basu et al., 2011). A similar study where subjects aged 47.0 ± 3.0 
years with metabolic syndrome consumed freeze-dried strawberries instead 
for 8 weeks did not either observe any change in BP (Basu et al., 2010b).  
Healthy men aged 35-51 years, with high BP (>140/90 mmHg) ingested 
pure anthocyanins for 4 weeks in a double-blind crossover study and 
alteration in BP was not observed after treatment (Hassellund et al., 2012). 
In a double-blind crossover acute meal study, healthy subjects aged 
44.55 ± 13.34 years consumed blackcurrant juice or placebo. No significant 
change in BP was observed between juice and placebo (Jin et al., 2011). 
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Table 3. Studies where no positive effects on blood pressure or vascular function was observed after anthocyanin 
intake. 
♂= men; sex not mentioned= both women and men or not mentioned in study 
Subjects (n) 
condition  
Duration of 
intervention 
Anthocyanin source Dose mg/d Reference  
n (♂)=10 24 hours Blueberry 
(frozen) 
348 (Del Bo′ et al., 
2013) 
Risk factor for 
cardiovascular 
disease 
n=18 
6 weeks Blueberry 
(freeze-dried) 
375 (Riso et al., 2012) 
Obese, insulin 
resistant 
n=32 
6 weeks Blueberry 
(freeze-dried) 
668 (Stull et al., 2010) 
Chronic smokers 
n=20 
3 weeks Blueberry  (McAnulty et al., 
2005) 
Metabolic 
syndrome 
n=36 
8 weeks Cranberry  
(juice) 
24.8 (Basu et al., 2011) 
Metabolic 
syndrome  
n=27 
8 weeks Strawberry 
(freeze-dried)  
154.0 (Basu et al., 2010b) 
Healthy  
n (♂)=31 
4 weeks Pure 640  (Hassellund et al., 
2012) 
Healthy 
n=20 
24 hours Blackcurrant (juice) ~50 (only 
delphinidin and 
cyanidin) 
(Jin et al., 2011) 
4.3 Animal and in vitro experiments 
Animal and in vitro model studies have been conducted to study potential 
mechanism behind blood pressure reduction caused by anthocyanins. 
Diebolt et al. (2001) observed increased endothelial NO activity in aorta 
vessels from rats when red wine polyphenols, including anthocyanins, were 
given. The study provided clear evidence that the red wine polyphenols 
could lower blood pressure under short-term oral administration. The blood 
pressure decreased without any changes in heart rate in the animals. The 
decrease of blood pressure was thought to be due to the increase of 
endothelial NO activity (Diebolt et al., 2001).  
When different fractions of red wine polyphenolic compounds were 
added to norepinephrine precontracted rat aorta, the activity of endothelium-
dependent vasorelaxation of anthocyanins were comparable with the 
original red wine polyphenolic compounds. The red wine powder contained 
64 mg anthocyanins/g red wine powder and the vasorelaxing effects were 
observed between concentrations of 10-4-10-3 g/L. The results clearly stated 
that the anthocyanin fraction of red wine polyphenols was responsible for 
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the vasorelaxing effects and were comparable with the original red wine 
polyphenols (Andriambeloson et al., 1998).   
A study examining the effect of cyanidin-3-glucoside on eNOS in bovine 
artery endothelial cells found anthocyanins to be associated with the 
upregulation eNOS. The results contribute to the evidence for the effects of 
anthocyanins participating in the maintaining of the blood pressure and 
improvement of dysfunctional endothelia via increased NO production (Xu 
et al., 2004). Similar findings were observed when human umbelicial vein 
endothelial cells were treated for 24 hours with the two anthocyanidins 
delphinidin and cyanidin. Increased protein levels of human eNOS was 
observed in vitro, especially for delphinidin (Lazzè et al., 2006). 
Newer studies seem to focus more on the effects of the metabolites 
rather than the intact anthocyanins since evidence for the vaso-relaxing 
effects points in the direction of the metabolites (Rodriguez-Mateos et al., 
2013).  
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5. Mechanism of action 
Some studies have attempted to suggest possible mechanistic pathways for 
the observed effects of anthocyanins on blood pressure. Following ingestion 
of anthocyanins, Zhu et al. (2011) observed improved FMD correlated with 
increased levels of cGMP in serum, used as an indicator of NO activity. The 
activation of the NO-cGMP signaling pathway therefore seem to be 
involved in the mechanism of action for the endothelial dependent 
vasorelaxation observed after anthocyanin supplementation (Zhu et al., 
2011). Improvement of FMD has also been shown to correlate with 
increasing plasma metabolites derived from anthocyanins in a study from 
Rodriguez-Mateos et al. (2013). Both increase in FMD and plasma 
metabolites was observed to peak 1-2 hours respective 6 hours after intake 
of blueberry polyphenols. In line with the increase of FMD and phenolic 
acids (hippuric-, vanillic- and homovanillic acids) a decrease of NADPH 
oxidase was observed suggesting a potential mechanism of action in which 
the bioavailability of NO increases as a results from the inhibition of 
NADPH oxidase. Indeed, all three phenolic acids have structural similarities 
with a known NADPH oxidase inhibitor; apocynin (Rodriguez-Mateos et 
al., 2013).  
A major anthocyanin metabolite, protocatechuic acid, have been 
observed both in vitro and in vivo to reduce monocyte adhesion to the 
endothelium in ApoE-deficient mice by inhibiting the expression of two 
adhesion molecules. Reduced activation of NF-κB, an important 
transcriptional regulator for the two adhesion molecules was also observed 
in vitro. All in all, these findings suggested that these major metabolites of 
anthocyanins have positive inverse effects on the formation on 
atherosclerotic lesions in apoE-deficient mice (Wang et al., 2010). Results 
from RCTs with healthy humans support the inhibitory effects of 
anthocyanins on NF-κB (Karlsen et al., 2007). The positive effects on the 
atherosclerotic lesions from the anthocyanin metabolite supports a 
functional epithelium, a crucial factor when considering maintenance of 
normal blood pressure. 
  Considering the low bioavailability of anthocyanins, the 
evidence from epidemiological studies and RCTs together with the potential 
mechanisms behind the effects observed both in animals and humans in 
vitro and in vivo all in all suggest that the lowering in blood pressure most 
probably is caused by anthocyanin metabolites rather than the intact 
anthocyanins themselves.  
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6. Discussion and Conclusion 
Foods contain a mixture of flavonoids and it is likely that observed  effects 
on blood pressure may be due to a specific anthocyanin or its derivatives 
and are aided by other subclasses of flavonoids (Cassidy et al., 2011). 
Consumers of high mean intake of flavonoids generally consume more 
fruits, vegetables and less trans- and saturated fats (McCullough et al., 
2012) which may influence results from epidemiological studies. Several 
participants in the study by Basu et al. (2010a) experienced gastrointestinal 
discomfort and problems when consuming the freeze dried blueberry 
powder, probably due to the increased amount of fiber consumption (Basu 
et al., 2010a). The association between lower blood pressure and 
consumption of some anthocyanin-rich food sources may therefore to some 
extent also depend on the fiber intake, since fiber has been found to 
correlate with lower risk of CVD (Mink et al., 2007). It is therefore possible 
that overall healthier diets and lifestyle may have residual-confounded the 
results of observed associations with blood pressure in some 
epidemiological studies, despite extensive adjustment for confounders. 
The use of different anthocyanin databases provides different estimations 
of anthocyanin contents in foods which leads to lower precision in the 
intake estimations and systematic differences between studies using 
different databases. Moreover, the use of different statistical models 
adjusting for different confounding factors across studies, may further have 
contributed to differences in results in some epidemiological studies – to 
different degree. Problems like these makes comparison between studies 
complex. Future studies should therefore aim to use more similar study 
designs and statistical models.  
Despite somewhat different results, many epidemiological studies show 
a beneficial inverse association between anthocyanin intake and blood 
pressure. However, cause and effect cannot be inferred from these studies. 
More double blinded, RCTs should be conducted with intakes of pure 
anthocyanins instead of mixtures of polyphenols, which contains substances 
that may interference with the results. Studies using pure, labelled 
anthocyanins would make it possible to identify the metabolites and their 
interaction with other substances and may contribute to a better 
understanding of the role anthocyanins play in hypertension as well. 
However, the possible inhibitory effects of excessive concentrations should 
be evaluated further before using pure anthocyanins in future study models. 
Regarding recovery studies of anthocyanins, there seem to be a lack of 
detection of all metabolites with the current available techniques, even 
though 13C-labeling is used (de Ferrars et al., 2014). The possibility for 
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chemical binding between anthocyanins and their metabolites and proteins 
may obstruct the detection of all metabolites in plasma and urine samples. 
This obstacle may be overcome by the continued widespread use of labeled 
anthocyanins (Wallace, 2011). 
In conclusion, there seem to be positive effects of anthocyanins on BP 
mainly in older subjects with already elevated risk of hypertension. 
However, additional RCTs using pure anthocyanins are needed to establish 
the cause and effect as well as dose-response relationships. The mechanisms 
of actions are not fully understood, but there are some evidence suggesting 
upregulation/activation of NO as a result of the metabolites derived from 
anthocyanins. More studies conducted on both animals and humans in vivo 
as well as in vitro with labeled anthocyanins and their metabolites may 
provide a possibility to establish cause and effect relationship for specific 
metabolites on the role of NO in anthocyanin induced lowering of blood 
pressure.   
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